Literature DB >> 13900321

Effective use of a new alkylating agent in doses lethal to bone marrow with protection by tourniquets of marrow in the extremis.

L E GOODMAN, A SCHILLING, S P KRAMER, A ULFOHN, S MILLER, S KRAVITZ, S D GABY, D BAKAL, B WITTEN, A M SELIGMAN.   

Abstract

Keywords:  ANTINEOPLASTIC AGENTS/therapy; BONE MARROW/pharmacology

Mesh：

Substances：

Year:  1961        PMID： 13900321

Source DB:  PubMed          Journal:  Surg Forum        ISSN： 0071-8041


× No keyword cloud information.
  1 in total

1.  Enzyme alterable alkylating agents. 8. Clinical trials with intra-arterial infusion of an alkylating agent with a half-life of 0.2 second.

Authors:  L E Goodman; A Ulfohn; S P Kramer; E H Cendana; A B Flores; D Bakal; S J Abrams; R L Hirschfeld; S Calle; C E Williamson; S Sass; B Witten; A M Seligman
Journal:  Ann Surg       Date:  1965-10       Impact factor: 12.969
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.